Definition of disease duration in ankylosing spondylitis

被引:44
|
作者
Feldtkeller, Ernst [1 ]
Erlendsson, Jon [2 ]
机构
[1] Ankylosing Spondylitis Int Federat, D-81671 Munich, Germany
[2] Ankylosing Spondylitis Int Federat, DK-8700 Horsens, Denmark
关键词
ankylosing spondylitis; disease duration; symptom onset; diagnosis delay;
D O I
10.1007/s00296-007-0499-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Two definitions of the "disease duration" of ankylosing spondylitis (AS) have been used in the literature: (1) duration since first symptoms connected with AS and (2) duration since diagnosis of AS. To investigate how useful these definitions are for research, we reinvestigated the data of four surveys completed by patients with AS in the years since 1996. We found that the majority of the patients remembered the age at first symptoms with an accuracy of <= 1 year, and that the difference between both definitions (the delay in diagnosis) was between 9.8 and 10.4 years on average, with extreme values of more than 30 years being not very seldom. Because the error made using the duration since diagnosis as "disease duration" is much larger than the inaccuracy taken into account using the duration since first symptoms, only the duration since first symptoms connected with AS should be used as definition for the term "disease duration" of AS.
引用
收藏
页码:693 / 696
页数:4
相关论文
共 50 条
  • [1] Definition of disease duration in ankylosing spondylitis
    Ernst Feldtkeller
    Jon Erlendsson
    Rheumatology International, 2008, 28 : 693 - 696
  • [2] Definition of disease flare in ankylosing spondylitis: The patients' perspective
    Brophy, S
    Calin, A
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (05) : 954 - 958
  • [3] lncRNA MEG3 is downregulated in ankylosing spondylitis and associated with disease activity, hospitalization time and disease duration
    Liu, Wei
    Huang, Lili
    Zhang, Cuiying
    Liu, Zuozhong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (01) : 291 - 297
  • [4] Ankylosing spondylitis and bowel disease
    Baeten, D
    De Keyser, F
    Mielants, H
    Veys, EM
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2002, 16 (04): : 537 - 549
  • [5] Ankylosing spondylitis and bowel disease
    Rudwaleit, Martin
    Baeten, Dominique
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (03): : 451 - 471
  • [6] A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis
    Fernando A. Sommerfleck
    Emilce E. Schneeberger
    Emilio E. Buschiazzo
    José A. Maldonado Cocco
    Gustavo Citera
    Clinical Rheumatology, 2012, 31 : 1599 - 1603
  • [7] A simplified version of Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with ankylosing spondylitis
    Sommerfleck, Fernando A.
    Schneeberger, Emilce E.
    Buschiazzo, Emilio E.
    Maldonado Cocco, Jose A.
    Citera, Gustavo
    CLINICAL RHEUMATOLOGY, 2012, 31 (11) : 1599 - 1603
  • [8] The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient's poor physical mobility
    Chen, Chun-Hsiung
    Chen, Hung-An
    Liao, Hsien-Tzung
    Liu, Chin-Hsiu
    Tsai, Chang-Youh
    Chou, Chung-Tei
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (07) : 1263 - 1267
  • [9] Disease and psychological status in ankylosing spondylitis
    Martindale, J.
    Smith, J.
    Sutton, C. J.
    Grennan, D.
    Goodacre, L.
    Goodacre, J. A.
    RHEUMATOLOGY, 2006, 45 (10) : 1288 - 1293
  • [10] Autoimmune thyroid disease in ankylosing spondylitis
    Emmungil, Hakan
    Erdogan, Mehmet
    Kalfa, Melike
    Karabulut, Gonca
    Kocanaogullari, Hayriye
    Inal, Vedat
    Aksu, Kenan
    Oksel, Fahrettin
    Kabasakal, Yasemin
    Keser, Gokhan
    CLINICAL RHEUMATOLOGY, 2014, 33 (07) : 955 - 961